UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Octavia Wealth Advisors LLC

Octavia Wealth Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 12.1% during the fourth quarter, HoldingsChannel reports. The fund owned 682 shares of the healthcare conglomerate’s stock after selling 94 shares during the period. Octavia Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $345,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the third quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the third quarter valued at $37,000. Finally, Quarry LP grew its holdings in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $524.78 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market cap of $482.95 billion, a P/E ratio of 33.86, a price-to-earnings-growth ratio of 1.38 and a beta of 0.62. The stock has a 50-day simple moving average of $547.07 and a 200-day simple moving average of $563.84.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on UNH. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $627.74.

View Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.